Platinum Industries Targets 35% CAGR by FY29 Amid Global Expansion and Diversification
Platinum Industries Ltd · Investor Presentation · 05 Nov 2026, 8:32 pm
Platinum Industries Targets 35% CAGR by FY29 Amid Global Expansion and Diversification Platinum Industries reported consolidated Q2FY27 revenue of ₹1,212.7 Mn, up 23.3% YoY, while EBITDA stood at ₹108.3 Mn with an 8.9% margin and PAT at ₹76.0 Mn. For H1FY27, revenue reached ₹2,302.0 Mn, up 7.7% YoY. The company targets a 35% revenue CAGR between FY26 and FY29, supported by fully operational domestic capacity of 60,000 TPA at Palghar and an upcoming 60,000 MTPA greenfield plant in Egypt by Q4FY27. Additionally, subsidiary Rivadu Lifesciences signed an exclusive India partnership on 28th Sep'26 with Korea's CAREGEN for Korglutide.
Original exchange filing (PDF)
More announcements from Platinum Industries Ltd
- Enclosed herewith transcript of Earnings call for Unaudited financial results for quarter and half year ended 30th september 2026. · 10 Nov 2026
- Enclosed herewith Monitoring Agency Report for the quarter ended September 30, 2026. · 05 Nov 2026
- Disclosure under Reg 30 of SEBI (LODR) for Modified Opinion on Unaudited Financial Results for Quarter and half year ended 30ths September 2026 · 05 Nov 2026
- Platinum Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Enclosed Unaudited Standalone and Consolidated Financial results for quarter and half year ended 30th september 2026. · 05 Nov 2026
- Outcome of Board Meeting for approving Unaudited Standalone and Consolidated Financials Results for quarter and half year ended 30th September 2026. · 05 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of .... · 05 Nov 2026
- PLATINUM INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 04 Nov 2026
